HPV vaccination for immunosuppressed women.
Ugeskr Laeger
; 185(28)2023 07 10.
Article
de Da
| MEDLINE
| ID: mdl-37539796
ABSTRACT
Immunocompromised women are at increased risk of having HPV detected and developing HPV-related diseases such as genital warts, anogenital dysplasia, and cancer. This review aims to summarize the current literature regarding the immunogenicity of the HPV vaccine in immunocompromised women and to discuss whether HPV vaccination may be able to reduce the risk of cervical dysplasia and cancer. HPV vaccination induces an immune response in these women; however, it is unknown whether vaccination is effective in reducing the risk of cervical dysplasia and cancer. Further research is needed.
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Condylomes acuminés
/
Dysplasie du col utérin
/
Tumeurs du col de l'utérus
/
Infections à papillomavirus
/
Vaccins contre les papillomavirus
Type d'étude:
Etiology_studies
Limites:
Female
/
Humans
Langue:
Da
Journal:
Ugeskr Laeger
Année:
2023
Type de document:
Article